Cite

    Lombardi, P. et al. (2022). Bevacizumab-induced hypertension as a predictor of clinical outcome in metastatic colorectal cancer: An individual patient data-based pooled analysis of two randomized studies and a systematic review of the literature. Cancer treatment reviews. p. . [Online].